Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update Summary

被引：10
作者：
Anderson, Kenneth
Ismaila, Nofisat
Kyle, Robert A.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Amer Soc Clin Oncol, Alexandria, VA USA
[3] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF ONCOLOGY PRACTICE | 2018年 / 14卷 / 04期
关键词：
D O I：
10.1200/JOP.17.00013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：266 / +
页数：5
相关论文
共 2 条
  • [1] Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update
    Anderson, Kenneth
    Ismaila, Nofisat
    Flynn, Patrick J.
    Halabi, Susan
    Jagannath, Sundar
    Ogaily, Mohammed S.
    Omel, Jim
    Raje, Noopur
    Roodman, G. David
    Yee, Gary C.
    Kyle, Robert A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (08) : 812 - +
  • [2] American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma
    Kyle, Robert A.
    Yee, Gary C.
    Somerfield, Mark R.
    Flynn, Patrick J.
    Halabi, Susan
    Jagannath, Sundar
    Orlowski, Robert Z.
    Roodman, David G.
    Twilde, Patricia
    Anderson, Kenneth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (17) : 2464 - 2472
1